Search

everythinglearnresearchcommunity

for

Search:↓

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

IL-18 signaling helps mature Tregs move into the thymus.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

ILC1-like cells can independently cause alopecia areata.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

ITK inhibitors may effectively treat alopecia areata.

Topical IKKα inhibitors may help prevent CCS tumours.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Targeting specific T cells may help treat alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

ILC1 cells contribute to hair loss in alopecia areata.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

IL-18 signaling helps mature Tregs move into the thymus.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Innate lymphoid cells help us understand and manage allergic diseases better.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.